US Archives - Page 2 of 79 - European Medical Journal

How Rheumatologists Choose Specialists to Refer To

Understanding referral patterns in rheumatic disease management is crucial to improving interdisciplinary care and patient outcomes.

Phase III Pembrolizumab Trial in Head and Neck Cancer: AACR 2025

Patients with newly diagnosed, locally advanced head and neck squamous cell carcinoma (HNSCC) may soon benefit from a major shift in treatment strategy, as phase III trial data show that perioperative pembrolizumab significantly improves outcomes when added to standard care.

Could This Berry Compound Help Protect the Aging Brain?

In a new randomized controlled trial, daily anthocyanin supplementation significantly improved inflammation and cardiometabolic biomarkers in older adults at risk for dementia, a finding that may have implications for both brain and cardiovascular health.

Exclusive E-Cigarette Use Linked to Lung and Blood Pressure Risks

A new longitudinal study from the All of Us Research Program sheds light on the potential cardiometabolic consequences of exclusive e-cigarette use and dual tobacco use in adults across the United States.

Inside the Hidden Threat of CNS Infections After Kidney Transplant

New 20-year study reveals that rare CNS infections in kidney transplant recipients carry high mortality and long-term neurological impact, with metagenomic sequencing crucial for diagnosis.

AMJ Dermatology 2 [Supplement 3] 2025

In this new article, discover recent clinical insights on clascoterone cream 1% and its potential role in addressing excess sebum…

Spotlight on Sebum Production

A recent study found that clascoterone cream 1% significantly reduces sebum production in patients with mild-to-moderate acne, suggesting…

FDA Fast Track Therapy Targets HER2-Mutated NSCLC: AACR 2025

Promising new data emerged on zongertinib, an investigational oral therapy targeting HER2 mutations in advanced non-small cell lung cancer (NSCLC), was presented at the AACR Annual Meeting 2025 in Chicago.

Are JAK Inhibitors Raising VTE Risk in Rheumatoid Arthritis?

In patients with rheumatoid arthritis (RA), understanding the risk of venous thromboembolism (VTE) is increasingly important as treatment strategies evolve.

Liquid Biopsy Detects Colorectal Cancer Recurrence Months Early: AACR 2025

At the American Association for Cancer Research (AACR) Annual Meeting 2025 in Chicago, new data revealed that a liquid biopsy using circulating tumor DNA (ctDNA) could detect colorectal cancer recurrence significantly earlier than imaging, with ctDNA signals appearing up to 416 days before clinical detection.